StockCIK 1533040

Phio Pharmaceuticals Corp. (PHIO): Insider Trades and Fund Holdings

In the past 12 months, Phio Pharmaceuticals Corp. insiders reported 7 open-market purchases worth $59K and 0 sales worth $0.

7Insider buys, 12 months

$59KBought by insiders, 12 months

$0Sold by insiders, 12 months

0Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 30, 2026.

Recent PHIO insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 30	Sep 29	Ronald Todd PlottDirector	Director	▲ BUY	5,000	1.04	$5K	+14%	Form 4 ↗
Sep 30	Sep 28	Ronald Todd PlottDirector	Director	▲ BUY	5,000	1.03	$5K	+16%	Form 4 ↗
Sep 25	Sep 24	Patricia A. BradfordDirector	Director	▲ BUY	6,500	1.01	$7K	+11%	Form 4 ↗
Sep 23	Sep 22	Robert J. BittermanCEO	CEO	▲ BUY	2,000	1.03	$2K	+0.6%	Form 4 ↗
Sep 16	Sep 15	Patricia A. BradfordDirector	Director	▲ BUY	12,000	1.03	$12K	+26%	Form 4 ↗
Aug 20	Aug 19	Ronald Todd PlottDirector	Director	▲ BUY	15,000	1.14	$17K	New	Form 4 ↗
Aug 19	Aug 18	Robert J. BittermanCEO	CEO	▲ BUY	10,000	1.06	$11K	+2.4%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sold	Latest
Ronald Todd Plott	Director	3	$27K	$0	Sep 30, 2026
Patricia A. Bradford	Director	2	$19K	$0	Sep 25, 2026
Robert J. Bitterman	CEO	2	$13K	$0	Sep 23, 2026

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →